Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Realty Trust
DLR
|
+$5.07B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.02B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.31B |
| 4 |
Canadian Natural Resources
CNQ
|
+$1.05B |
| 5 |
US Bancorp
USB
|
+$630M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.53B |
| 2 |
Apple
AAPL
|
+$2.36B |
| 3 |
Biogen
BIIB
|
+$1.67B |
| 4 |
Goldman Sachs
GS
|
+$1.11B |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.03% |
| 2 | Technology | 12.36% |
| 3 | Industrials | 11.39% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Staples | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Freeport-McMoran
FCX
$96.9B
| $357M | 0.12% |
15,273,000
+3,800,000
| +33% | +$105M |
|
177
Pfizer
PFE
$150B
| $357M | 0.12% |
12,068,300
+1,054,000
| +10% | +$30.2M |
|
|
BLUE
178
DELISTED
bluebird bio
BLUE
| $356M | 0.12% |
299,236
+28,811
| +11% | +$19.3M |
|
179
Kimberly-Clark
KMB
$36.2B
| $347M | 0.12% |
3,000,000
-129,000
| -4% | -$14.3M |
|
|
K
180
DELISTED
Kellanova
K
| $345M | 0.12% |
5,609,805
| – | – |
|
181
Cencora
COR
$60B
| $342M | 0.12% |
3,793,814
-203,387
| -5% | -$17.4M |
|
182
Abbott
ABT
$192B
| $337M | 0.11% |
7,485,000
| – | – |
|
|
SIX
183
DELISTED
Six Flags Entertainment Corp.
SIX
| $336M | 0.11% |
7,788,877
+1,847,477
| +31% | +$72.7M |
|
184
ITT
ITT
$19.4B
| $333M | 0.11% |
8,239,121
+3,339,000
| +68% | +$140M |
|
185
Xcel Energy
XEL
$49.1B
| $328M | 0.11% |
9,131,000
| – | – |
|
186
Verisk Analytics
VRSK
$23.5B
| $314M | 0.11% |
4,897,300
-1,906,000
| -28% | -$119M |
|
187
FedEx
FDX
$77.3B
| $313M | 0.11% |
1,800,000
| – | – |
|
188
Target
TGT
$69.9B
| $310M | 0.11% |
4,080,000
+2,080,000
| +104% | +$140M |
|
|
VAL
189
DELISTED
Valspar
VAL
| $309M | 0.1% |
3,572,585
| – | – |
|
190
TJX Companies
TJX
$169B
| $309M | 0.1% |
9,000,000
| – | – |
|
|
VMW
191
DELISTED
VMware, Inc
VMW
| $308M | 0.1% |
3,730,000
| – | – |
|
192
Myriad Genetics
MYGN
$309M
| $305M | 0.1% |
8,940,702
+7,268
| +0.1% | +$258K |
|
193
RPM International
RPM
$14.7B
| $304M | 0.1% |
6,000,000
| – | – |
|
|
AGU
194
DELISTED
Agrium
AGU
| $301M | 0.1% |
3,180,000
+801,200
| +34% | +$75.1M |
|
195
IDEX
IEX
$17.7B
| $295M | 0.1% |
3,788,000
+108,000
| +3% | +$8.04M |
|
196
Analog Devices
ADI
$187B
| $294M | 0.1% |
5,299,826
+1,000,000
| +23% | +$51.1M |
|
197
General Mills
GIS
$20.4B
| $289M | 0.1% |
5,420,000
| – | – |
|
|
MNDT
198
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $288M | 0.1% |
9,124,313
+3,169,800
| +53% | +$97.3M |
|
|
ALTR
199
DELISTED
Altera Corp
ALTR
| $286M | 0.1% |
7,750,000
| – | – |
|
200
Old Republic International
ORI
$10.3B
| $286M | 0.1% |
19,562,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q4 2014 Portfolio in Review
As of Q4 2014, Capital Research Global Investors held 466 positions worth $295B, up 2% from $289B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Capital Research Global Investors's Q4 2014 filing shows 25 new, 139 increased, 121 reduced and 25 closed positions. Its largest new stake was Express Scripts Holding Company: 5,069,483 shares worth $429M. The largest sale was Gilead Sciences, an estimated $2.53B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Capital Research Global Investors's largest Q4 2014 buy was Express Scripts Holding Company: 5,069,483 shares worth $429M.
- Capital Research Global Investors added most to Digital Realty Trust in Q4 2014, an estimated $5.07B increase.
- Capital Research Global Investors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $2.53B.
- Capital Research Global Investors fully exited Yum! Brands in Q4 2014, selling an estimated $315M.
- Capital Research Global Investors's ten largest holdings make up 26% of its $295B portfolio in Q4 2014.
- Capital Research Global Investors opened 25 new positions and closed 25 in Q4 2014.
- Capital Research Global Investors's portfolio value rose 2% quarter-over-quarter to $295B.
Based on Capital Research Global Investors's 13F filing for Q4 2014, filed 13 Feb 2015.